Cited by 96Adrenal Hormones and DisordersDermatology and Skin DiseasesPsoriasis: Treatment and Pathogenesis

Steroid synthesis by primary human keratinocytes; implications for skin disease

Hannen, Rosalind F., Michael, Anthony E., Jaulim, Adil, Bhogal, Ranjit, Burrin, Jacky M., Philpott, Michael P.·2011·Biochemical and Biophysical Research Communications

Abstract

Cortisol-based therapy is one of the most potent anti-inflammatory treatments available for skin conditions including psoriasis and atopic dermatitis. Previous studies have investigated the steroidogenic capabilities of keratinocytes, though none have demonstrated that these skin cells, which form up to 90% of the epidermis are able to synthesise cortisol. Here we demonstrate that primary human keratinocytes (PHK) express all the elements required for cortisol steroidogenesis and metabolise pregnenolone through each intermediate steroid to cortisol. We show that normal epidermis and cultured PHK express each of the enzymes (CYP11A1, CYP17A1, 3βHSD1, CYP21 and CYP11B1) that are required for cortisol synthesis. These enzymes were shown to be metabolically active for cortisol synthesis since radiometric conversion assays traced the metabolism of [7-(3)H]-pregnenolone through each steroid intermediate to [7-(3)H]-cortisol in cultured PHK. Trilostane (a 3βHSD1 inhibitor) and ketoconazole (a CYP17A1 inhibitor) blocked the metabolism of both pregnenolone and progesterone. Finally, we show that normal skin expresses two cholesterol transporters, steroidogenic acute regulatory protein (StAR), regarded as the rate-determining protein for steroid synthesis, and metastatic lymph node 64 (MLN64) whose function has been linked to cholesterol transport in steroidogenesis. The expression of StAR and MLN64 was aberrant in two skin disorders, psoriasis and atopic dermatitis, that are commonly treated with cortisol, suggesting dysregulation of epidermal steroid synthesis in these patients. Collectively these data show that PHK are capable of extra-adrenal cortisol synthesis, which could be a fundamental pathway in skin biology with implications in psoriasis and atopic dermatitis.

Integrity signals

Registry

Crossref · 10.1016/j.bbrc.2010.11.059

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Epidermal keratinocytes express the cholesterol transporters TSPO and MLN64.

    “In addition to StAR, epidermal keratinocytes also express cholesterol transporters TSPO and MLN64 [54, 63].”
  • StAR expression has been detected in epidermal keratinocytes, sebocytes, outer root sheath of hair follicles, vascular tissues, and eccrine ducts.

    “The expression of StAR has been detected by RT-PCR and immunohistochemical analyses in epidermal keratinocytes, sebocytes, outer root sheath of hair follicles (HFs), vascular tissues and eccrine ducts [62, 63, 69, 84].”
  • StAR expression is decreased or absent in psoriatic and atopic dermatitis skin compared with normal skin.

    “StAR expression has been demonstrated to be decreased or absent in psoriatic and atopic dermatitis when compared to normal skin tissues [62, 63].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hannen, R. F., Michael, A. E., Jaulim, A., Bhogal, R., Burrin, J. M., & Philpott, M. P.
Affiliations
  • Queen Mary University of London (GB)
  • University of London (GB)
  • Unilever (United Kingdom) (GB)
Corresponding author
Hannen, Rosalind F.
Venue
Biochemical and Biophysical Research Communications
Publisher
Elsevier BV
Published
2011-01
Volume
404
Issue
1
Pages
62-67
ISSN
0006-291X (ISSN-L)
OpenAlex
W1969061052
Cited by
96
References
21
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 11 · 2022: 7 · 2021: 4 · 2020: 6 · 2019: 5 · 2018: 6 · 2017: 5 · 2016: 4 · 2015: 11 · 2014: 5 · 2013: 9 · 2012: 9
FWCI
5.31
Type
journal article
Language
en
Open access
closed
Locations
  • Biochemical and Biophysical Research Communications (publishedVersion)
  • PubMed (publishedVersion)
Funders
Biotechnology and Biological Sciences Research Council
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
Keywords
keratinocytes, cortisol production, pregnenolone metabolism, CYP11A1, CYP17A1, CYP21, CYP11B1, steroidogenic acute regulatory protein, MLN64, cholesterol transport, psoriasis, atopic dermatitis, trilostane, ketoconazole
MeSH terms
Cells, Cultured, Dermatitis, Atopic, Epidermis, Humans, Hydrocortisone, Pregnenolone, Psoriasis, Steroid Hydroxylases, 3-Hydroxysteroid Dehydrogenases, Keratinocytes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review